Bio Impact Capital LLC Ultragenyx Pharmaceutical Inc. Transaction History
Bio Impact Capital LLC
- $641 Million
- Q3 2024
A detailed history of Bio Impact Capital LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Bio Impact Capital LLC holds 329,733 shares of RARE stock, worth $14.8 Million. This represents 2.86% of its overall portfolio holdings.
Number of Shares
329,733
Previous 380,552
13.35%
Holding current value
$14.8 Million
Previous $15.6 Million
17.11%
% of portfolio
2.86%
Previous 2.51%
Shares
3 transactions
Others Institutions Holding RARE
# of Institutions
325Shares Held
85.7MCall Options Held
520KPut Options Held
406K-
Vanguard Group Inc Valley Forge, PA9.95MShares$445 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$251 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA5.12MShares$229 Million0.91% of portfolio
-
Wellington Management Group LLP Boston, MA4.17MShares$186 Million0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.07MShares$137 Million0.02% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $3.13B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...